[ CYPHER CODE #1590 ]
Ozempic didn't just shrink appetites. It exposed the junk food economy.

[ CYPHER CODE #1591 ]
Big Food was built on cravings people could not turn off.

[ CYPHER CODE #1592 ]
When Americans eat less, the supply chain feels it.

BRIEFING

Grant here. Injectable weight loss drugs like Ozempic are taking the world by storm. People, especially in the U.S., are using these "magic" injectables to shed pounds, and they're being used in such a surplus that it's not only waistlines that are shrinking, but the food supply chain is also taking a hit. Let’s break it down.

A viral Polymarket post says drugs like Ozempic are now tied to more than 850,000 fewer annual truckloads of food and beverage deliveries in the U.S. That's a massive reduction in food demand, and the post is definitely getting plenty of attention because it connects two things that a lot of folks don't put together: weight-loss drugs and freight volume. One person under the post joked that Ozempic may be doing more for American truck emissions than any climate policy ever has, which is both funny and true.

SOURCE

America has long built an enormous food economy around one basic assumption: people would keep eating. And not just a little, but a lot.

More snacks. More soda. More fast food. More late-night runs. More grocery carts loaded with processed junk. And, of course, more trucks moving all of it across the country.

Then, in walked GLP-1 drugs, and the suddenly, the "junk food" economy started to take a hit.

Cornell research found that households using GLP-1 medications like Ozempic and Wegovy reduced grocery spending by an average of 5.3% within six months of starting the drugs. Among higher-income households, the reduction was more than 8%, and spending at fast-food restaurants, coffee shops, and other quick-service restaurants fell by about 8%. And, not too shockingly, the sharpest grocery declines showed up in ultra-processed, calorie-dense categories like savory snacks, sweets, baked goods, and cookies.

This really does just boil down to simple math and smarter food choices.

If millions of people start buying less food, stop hitting the drive-thru, and cut back on sugary, greasy stuff, the entire industry starts to take a real, measurable hit. These choices that people are making while using drugs like Ozempic are rippling through grocery stores, restaurants, food companies, warehouses, distributors, and eventually the truck lanes.

IndexBox, citing a FreightWaves analysis, reported that GLP-1 drugs are already beginning to influence food freight demand. The analysis points to an estimated reduction in total caloric food demand of about 3%.

DEBRIEFING

I mean, it's not entirely surprising that we're seeing this kind of shift. After all, simple logic shows that if people are injecting a drug to eat less, obviously, more food is going to sit on the shelf.

But what's pretty interesting is the scale and speed at which it's happening.

America’s food economy was practically built around an endless appetite. The Americans literally have a worldwide reputation for "packing it away." But it's not that we're necessarily hungrier than other countries. It's also important to note how a lot of food here in the U.S. is engineered. A lot of the foods that Americans eat on a daily or weekly basis are designed to be highly craved, and then there's also our cultural habits around routine snacking, supersized portions, convenience runs, and sugary drinks.

Perhaps this could be all by design. Maybe it's a way for the government to reduce food production, like one of the commenters stated in the post above.

But tin foil hat theories or no, it's clear that GLP-1s are changing the game in more ways than one.

NOW YOU KNOW

Ozempic didn’t just shrink appetites. It put the overconsumption economy on notice.

Following recent reports that Congress is considering a nationwide voter ID requirement for federal elections, do you support requiring voters to show identification before casting a ballot?

By completing the poll, you agree to receive emails from Cypher-News.com, occasional offers from our partners and that you've read and agree to our privacy policy and legal statement.